Asian Journal Of Social Pharmacy

Asian Journal of Social Pharmacy

20 June 2017, Volume 12 Issue 2 Previous Issue    Next Issue

Application of SWOT Analysis and Porter’s Five Forces Analysis to State-owned Enterprise Affiliated Hospitals in China

Wang Tao, Wu Zhi’ang, Li Shuchuen

2017, 12 (2): 41–49;

Abstract ( 1008 ) PDF (486KB) ( 1269 )

Measures to Speed up Drug Review Process in Japan and Its Implications

Shi Wenwen, Sun Lihua

2017, 12 (2): 50–56;

Abstract ( 517 ) PDF (571KB) ( 2597 )

Analysis of New Drug Registration for Biological Products from 2010 to 2015 in China

Liu Dandan, Chen Yuwen

2017, 12 (2): 57–63;

Abstract ( 399 ) PDF (652KB) ( 1011 )

Problems of Fake Anti-malarial Drugs in Cambodia

Tem Darina, Mao Ningying

2017, 12 (2): 64–70;

Abstract ( 435 ) PDF (606KB) ( 720 )

Management of Subjects in Phase I Clinical Trials for New Drug

Qian Cuihong, Lian Guiyu

2017, 12 (2): 71–73;

Abstract ( 380 ) PDF (376KB) ( 668 )

Research on Economic Evaluation of Rare Diseases

Li Tongtong, Zhang Fang

2017, 12 (2): 74–80;

Abstract ( 367 ) PDF (531KB) ( 547 )

Influence Factors on Psychological Empowerment of Pharmaceutical Sales Representatives

Pan Shuang, Wu Zhi’ang

2017, 12 (2): 81–87;

Abstract ( 424 ) PDF (504KB) ( 702 )